Cargando…
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine
In the field of predictive, preventive and personalised medicine, researchers are keen to identify novel and reliable ways to predict and diagnose disease, as well as to monitor patient response to therapeutic agents. In the last decade alone, the sensitivity of profiling technologies has undergone...
Autores principales: | Hagan, Suzanne, Martin, Eilidh, Enríquez-de-Salamanca, Amalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942926/ https://www.ncbi.nlm.nih.gov/pubmed/27413414 http://dx.doi.org/10.1186/s13167-016-0065-3 |
Ejemplares similares
-
Education in predictive, preventive and personalised medicine
Publicado: (2011) -
Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients
por: Brunmair, Julia, et al.
Publicado: (2022) -
General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2012) -
Tear Fluid Biomarkers and Quality of Life in People with Type 2 Diabetes and Dry Eye Disease
por: Byambajav, Mungunshur, et al.
Publicado: (2023) -
Tear and Plasma Levels of Cytokines in Patients with Uveitis: Search for Active Disease Biomarkers
por: García-Onrubia, Luis, et al.
Publicado: (2022)